[go: up one dir, main page]

NO20050688L - Fast stoff farmasoytiske preparater inneholdende telmisartan - Google Patents

Fast stoff farmasoytiske preparater inneholdende telmisartan

Info

Publication number
NO20050688L
NO20050688L NO20050688A NO20050688A NO20050688L NO 20050688 L NO20050688 L NO 20050688L NO 20050688 A NO20050688 A NO 20050688A NO 20050688 A NO20050688 A NO 20050688A NO 20050688 L NO20050688 L NO 20050688L
Authority
NO
Norway
Prior art keywords
compositions
solid pharmaceutical
pharmaceutical preparations
preparations containing
containing telmisartan
Prior art date
Application number
NO20050688A
Other languages
English (en)
Other versions
NO334449B1 (no
Inventor
Manabu Nakatani
Toshimitsu Ohki
Sawada Takeshi
Kenzo Toyoshima
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31984063&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20050688(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20050688L publication Critical patent/NO20050688L/no
Publication of NO334449B1 publication Critical patent/NO334449B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen angår nye faste farmasøytiske preparater omfattende angiotensin-II -reseptorantagonisten telmisartan, et basisk middel, et overflateaktivt middel eller emulgator og et vannløselig fortynningsmiddel, feks. i form av granuler eller i form av et pulver, så vel som faste preparater klare for oral anvendelse/inntak, f.eks. kapsel- og tablett-preparater fremstilt fra nevnte farmasøytiske preparater og metoder for å produsere nevnte preparater og preparater ved bruk av en fluidisert-sjikt-granuleringsprosess eller en sprøytetørkeprosess.
NO20050688A 2002-09-24 2005-02-09 Farmasøytiske preparater omfattende telmisartan samt fremstilling av slike NO334449B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10244681A DE10244681A1 (de) 2002-09-24 2002-09-24 Neue feste Telmisartan enthaltende pharmazeutische Formulierungen und deren Herstellung
PCT/EP2003/010382 WO2004028505A1 (en) 2002-09-24 2003-09-18 Solid pharmaceutical formulations comprising telmisartan

Publications (2)

Publication Number Publication Date
NO20050688L true NO20050688L (no) 2005-03-23
NO334449B1 NO334449B1 (no) 2014-03-03

Family

ID=31984063

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050688A NO334449B1 (no) 2002-09-24 2005-02-09 Farmasøytiske preparater omfattende telmisartan samt fremstilling av slike

Country Status (32)

Country Link
EP (1) EP1545467B1 (no)
JP (1) JP4606166B2 (no)
KR (2) KR101188650B1 (no)
CN (2) CN1684665A (no)
AR (2) AR041370A1 (no)
AT (1) ATE372765T1 (no)
AU (1) AU2003270220B2 (no)
BR (1) BR0314687A (no)
CA (1) CA2499878C (no)
CY (1) CY1107075T1 (no)
DE (2) DE10244681A1 (no)
DK (1) DK1545467T3 (no)
EA (1) EA009237B1 (no)
EC (1) ECSP055688A (no)
ES (1) ES2294312T3 (no)
HR (1) HRP20050280B1 (no)
IL (1) IL167610A (no)
ME (1) MEP46008A (no)
MX (1) MXPA05003039A (no)
MY (1) MY136524A (no)
NO (1) NO334449B1 (no)
NZ (1) NZ539522A (no)
PE (1) PE20040418A1 (no)
PL (1) PL206396B1 (no)
PT (1) PT1545467E (no)
RS (1) RS51756B (no)
SI (1) SI1545467T1 (no)
TW (1) TWI319319B (no)
UA (1) UA81781C2 (no)
UY (1) UY27995A1 (no)
WO (1) WO2004028505A1 (no)
ZA (1) ZA200501087B (no)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10319450A1 (de) * 2003-04-30 2004-11-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung des Telmisartan Natriumsalzes
PT1586310E (pt) * 2004-04-15 2007-02-28 Helm Ag Processo para a preparação de adsorvatos de valsartan na forma de pó solto
US20060078615A1 (en) * 2004-10-12 2006-04-13 Boehringer Ingelheim International Gmbh Bilayer tablet of telmisartan and simvastatin
MX2007004426A (es) 2004-10-15 2007-06-14 Teva Pharma Procesos para preparar telmisartan.
WO2006050509A2 (en) * 2004-11-03 2006-05-11 Teva Pharmaceutical Industries Ltd. Amorphous and polymorphic forms of telmisartan sodium
KR20070085801A (ko) * 2004-11-05 2007-08-27 베링거 인겔하임 인터내셔날 게엠베하 텔미사르탄 및 암로디핀을 포함하는 2층 정제
US9149433B2 (en) * 2004-11-30 2015-10-06 Basf Corporation Method for formation of micro-prilled polymers
CN100370984C (zh) * 2005-03-11 2008-02-27 浙江泰利森药业有限公司 替米沙坦分散片及其制备方法
AU2005338461A1 (en) * 2005-11-22 2007-05-31 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions of telmisartan
US8637078B2 (en) * 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
EP2269583B1 (en) 2006-06-16 2014-08-13 LEK Pharmaceuticals d.d. Pharmaceutical composition comprising hydrochlorothiazide and telmisartan
GB0613925D0 (en) * 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
EP1970053A1 (en) * 2007-03-14 2008-09-17 Boehringer Ingelheim Pharma GmbH & Co. KG Pharmaceutical composition
FR2918277B1 (fr) * 2007-07-06 2012-10-05 Coretecholding Nouveau procede de production de formes pharmaceutiques seches hydrodispersibles et les compositions hydrodispersibles ainsi obtenues
WO2009135646A2 (en) 2008-05-05 2009-11-12 Farmaprojects, Sa Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
CZ301070B6 (cs) * 2008-07-31 2009-10-29 Zentiva, A. S. Telmisartan tablety
AR072883A1 (es) 2008-07-31 2010-09-29 Takeda Pharmaceutical COMPOSICIoN FARMACÉUTICA SoLIDA CON EL COMPUESTO (5-METIL-2-OXO-1,3-DIOXOL-4-IL)METIL2-ETOXI-1-{[2' -(5-OXO-4,5-DIHIDRO-1,2,4-OXADIAZOL-3-IL)BIFENIL-4-IL]METIL}-1H-BENCIMIDAZOL-7-CARBOXILATO Y UN DIURÉTICO PARA LA PROFILAXIS O TRATAMIENTO DE ENFERMEDADES DEL APARATO CIRCULATORIO.
EP2432452B1 (de) * 2009-05-20 2016-07-27 Boehringer Ingelheim Vetmedica GmbH Pharmazeutische telmisartan-trinklösung
SI2443094T1 (sl) 2009-06-19 2013-08-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo telmisartana
WO2011002425A2 (en) 2009-07-02 2011-01-06 Bilgig Mahmut Pharmaceutical composition increasing solubility and stability
WO2011002423A2 (en) 2009-07-02 2011-01-06 Mahmut Bilgic Solubility enhancing pharmaceutical composition
JP2011136908A (ja) * 2009-12-25 2011-07-14 Kyowa Yakuhin Kogyo Kk アンギオテンシンｉｉ受容体拮抗剤を含む固形製剤および固形製剤におけるアンギオテンシンｉｉ受容体拮抗剤の保存安定性向上方法
CA2706292A1 (en) * 2010-05-28 2011-11-28 Pharmascience Inc. A stable pharmaceutical formulation comprising telmisartan and hydrochlorothiazide
WO2011161123A2 (en) 2010-06-21 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Multilayer pharmaceutical tablet comprising telmisartan and a diuretic
TWI564008B (zh) * 2010-09-30 2017-01-01 鹽野義製藥股份有限公司 難溶性藥物之溶解性改善製劑
CN102133189B (zh) * 2011-03-18 2012-06-27 海南美兰史克制药有限公司 替米沙坦脂质体固体制剂
WO2013100112A1 (ja) * 2011-12-28 2013-07-04 ニプロ株式会社 アンギオテンシンｉｉ拮抗作用を有する化合物を含有する固形医薬組成物
EP2612658A1 (en) 2012-01-05 2013-07-10 Laboratorios Lesvi, S.L. Pharmaceutical compositions of 4'-[(1,4'dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid and is 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide
WO2014068507A1 (en) 2012-11-02 2014-05-08 Abbott Healthcare Pvt. Ltd. Solid oral pharmaceutical compositions of telmisartan, essentially free of surfactants
WO2014119767A1 (ja) 2013-01-31 2014-08-07 沢井製薬株式会社 テルミサルタンとヒドロクロロチアジドとを含有する多層錠剤
JP6218664B2 (ja) * 2013-04-04 2017-10-25 沢井製薬株式会社 テルミサルタン含有錠剤
JP6344678B2 (ja) * 2013-09-27 2018-06-20 キョーリンリメディオ株式会社 テルミサルタン含有製剤及びその製造方法
CN104688696B (zh) * 2013-12-04 2017-12-19 长春海悦药业股份有限公司 一种含有坎地沙坦酯的药物组合物
JP6428340B2 (ja) * 2014-05-23 2018-11-28 ニプロ株式会社 テルミサルタンを含む医薬組成物の造粒方法
JP6440294B2 (ja) * 2014-07-01 2018-12-19 大原薬品工業株式会社 テルミサルタン含有フィルムコーティング錠剤
EP2979691A1 (en) 2014-07-30 2016-02-03 Boehringer Ingelheim International GmbH Oral disintegrating tablet
WO2016080357A1 (ja) * 2014-11-19 2016-05-26 ニプロ株式会社 口腔内崩壊錠の製造方法
JP5827428B1 (ja) * 2015-01-15 2015-12-02 日新製薬株式会社 テルミサルタン含有錠剤
CN104739833A (zh) * 2015-02-16 2015-07-01 江苏欧信医药化工有限公司 含替米沙坦和瑞舒伐他汀钙的复方双层片剂及其制备方法
JP5956034B1 (ja) * 2015-07-27 2016-07-20 エルメッド エーザイ株式会社 テルミサルタン含有医薬組成物
CN107982232A (zh) * 2018-01-29 2018-05-04 威特(湖南)药业有限公司 替米沙坦片及其制备方法
CN109350604B (zh) * 2018-11-20 2020-04-21 广州迈达康医药科技有限公司 一种替米沙坦肠溶片及其制备方法
CN110934848B (zh) * 2019-12-20 2022-02-15 江西杏林白马药业股份有限公司 一种替米沙坦胶囊及其制备方法
CN111265488B (zh) * 2020-03-18 2021-11-12 重庆康刻尔制药股份有限公司 一种替米沙坦片及其制备方法
CN112870174A (zh) * 2021-02-08 2021-06-01 天方药业有限公司 一种替米沙坦片剂的制备方法
CN115245497A (zh) * 2021-04-26 2022-10-28 武汉伯睿科医药科技有限公司 替米沙坦胶囊及其制备工艺
US20240390332A1 (en) 2023-05-24 2024-11-28 Boehringer Ingelheim Vetmedica Gmbh Combination treatment and/or prevention of renal diseases and/or hypertension in non-human mammals comprising one or more SGLT-2 inhibitors and telmisartan

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW442301B (en) * 1995-06-07 2001-06-23 Sanofi Synthelabo Pharmaceutical compositions containing irbesartan
AU1042199A (en) * 1998-11-06 2000-05-29 Boehringer Ingelheim International Gmbh Antihypertensive medicaments containing lacidipine and telmisartan
WO2000027396A1 (en) * 1998-11-06 2000-05-18 Glaxo Group Limited Medicaments based on combinations of lacidipine and telmisartan or of physiological derivatives thereof
FR2787330A1 (fr) * 1998-12-18 2000-06-23 Sanofi Sa Composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et un immunosuppresseur pour la prevention ou le traitement des complications vasculaires du rejet de greffe
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
JP2001139461A (ja) * 1999-11-10 2001-05-22 Ohta Pharmaceut Co Ltd 速崩壊性錠剤
JP2001278812A (ja) * 2000-03-27 2001-10-10 Kyoto Pharmaceutical Industries Ltd 錠剤用崩壊剤及びこれを用いた錠剤
KR100876302B1 (ko) * 2002-01-16 2008-12-31 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 사실상 비결정질 형태인 텔미사르탄의 제조방법

Also Published As

Publication number Publication date
DE60316323T2 (de) 2008-01-17
MXPA05003039A (es) 2005-05-27
UA81781C2 (uk) 2008-02-11
NZ539522A (en) 2006-10-27
HRP20050280B1 (hr) 2014-01-03
AU2003270220B2 (en) 2009-06-04
NO334449B1 (no) 2014-03-03
CN1684665A (zh) 2005-10-19
WO2004028505A1 (en) 2004-04-08
JP4606166B2 (ja) 2011-01-05
MEP46008A (en) 2011-02-10
SI1545467T1 (sl) 2008-02-29
CA2499878A1 (en) 2004-04-08
PT1545467E (pt) 2007-11-27
CA2499878C (en) 2012-03-13
CY1107075T1 (el) 2012-10-24
KR101107508B1 (ko) 2012-01-31
EP1545467B1 (en) 2007-09-12
DE10244681A1 (de) 2004-04-08
ECSP055688A (es) 2005-05-30
RS51756B (sr) 2011-12-31
EA009237B1 (ru) 2007-12-28
ES2294312T3 (es) 2008-04-01
TW200418463A (en) 2004-10-01
KR20110122882A (ko) 2011-11-11
KR101188650B1 (ko) 2012-10-09
KR20050053690A (ko) 2005-06-08
DK1545467T3 (da) 2007-11-05
TWI319319B (en) 2010-01-11
AR041370A1 (es) 2005-05-11
CN101785769A (zh) 2010-07-28
MY136524A (en) 2008-10-31
PE20040418A1 (es) 2004-08-16
PL206396B1 (pl) 2010-08-31
AU2003270220A1 (en) 2004-04-19
EA200500405A1 (ru) 2005-10-27
JP2006502194A (ja) 2006-01-19
AR087239A2 (es) 2014-03-12
RS20050239A (en) 2007-06-04
ZA200501087B (en) 2006-11-29
DE60316323D1 (de) 2007-10-25
HRP20050280A2 (en) 2006-05-31
PL374347A1 (en) 2005-10-17
EP1545467A1 (en) 2005-06-29
BR0314687A (pt) 2005-08-02
IL167610A (en) 2009-02-11
UY27995A1 (es) 2004-05-31
ATE372765T1 (de) 2007-09-15

Similar Documents

Publication Publication Date Title
NO20050688L (no) Fast stoff farmasoytiske preparater inneholdende telmisartan
JP2019089805A5 (no)
JP2016515528A5 (no)
WO2009043844A3 (en) Orodispersible tablets
WO2004012699A3 (en) Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent
JP2011098964A5 (no)
JP2009530415A5 (no)
MXPA04007427A (es) Formulaciones de azitromicina granuladas por via seca.
JP2008523109A (ja) ゾニサミドの安定医薬製剤及びそれらの製造のための方法
NO20064934L (no) Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
KR20100103824A (ko) 약학적 조성물
RS55392B1 (sr) Brzo topljiva formulacija za oralno doziranje
JP5461565B2 (ja) 有機溶媒を使用したモキシフロキサシンの湿式造粒法
TR201620151A2 (en) ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING TADALAFIL AND DAPOXETIN
JP6308938B2 (ja) 粒状物を製造する方法
JP6476331B2 (ja) イソニアジドの顆粒およびリファペンチンの顆粒を含む分散性錠剤の形態の抗結核性の安定な医薬組成物ならびにその製造方法
JP2008169135A (ja) グリメピリド組成物の製造方法
JP3786287B2 (ja) 塩酸ベニジピン含有医薬組成物
JP2015086194A (ja) ラベプラゾールナトリウム含有粒子の製造方法及びそれを含む医薬組成物
JP2002012540A (ja) 水易溶性薬物含有錠剤
JP6096328B2 (ja) 口腔内崩壊錠
AU663000B2 (en) Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions
JP2015151337A (ja) 医薬用組成物の製造方法、医薬用組成物、及び口腔内崩壊錠
JP2009538905A (ja) 感湿性薬物を含んで成る安定性製剤及びその製造方法
JP2015193560A (ja) 医薬組成物

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees